ACSS2 and central nervous system cancer: This resonates with the high frequency of IDH1MUT in LGG cohorts and clarifies the observed association of ACSS2 expression and LGG patient survival, potentially reflecting the differences in ACSS2 expression and patient survival between IDH1MUT and IDH1WT glioma.